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Abstract
Rapid yet accurate pKa prediction for drug-like molecules is a key challenge in com-
putational chemistry. This study uses PM6-DH+/COSMO, PM6/COSMO, PM7/COSMO,
PM3/COSMO, AM1/COSMO, PM3/SMD, AM1/SMD, and DFTB3/SMD to predict
the pKa values of 53 amine groups in 48 drug-like compounds. The approach uses an
isodesmic reaction where the pKa value is computed relative to a chemically related
reference compound for which the pKa value has been measured experimentally or
estimated using a standard empirical approach. The AM1- and PM3-based methods
perform best with RMSE values of 1.4 - 1.6 pH units that have uncertainties of ±0.2-0.3
pH units, which make them statistically equivalent. However, for all but PM3/SMD
and AM1/SMD the RMSEs are dominated by a single outlier, cefadroxil, caused by
proton transfer in the zwitterionic protonation state. If this outlier is removed, the
RMSE values for PM3/COSMO and AM1/COSMO drop to 1.0 ± 0.2 and 1.1 ± 0.3,
while PM3/SMD and AM1/SMD remain at 1.5 ± 0.3 and 1.6 ± 0.3/0.4 pH units,
making the COSMO-based predictions statistically better than the SMD-based pre-
dictions. So for pKa calculations where a zwitterionic state is not involved or proton
transfer in a zwitterionic state is not observed then PM3/COSMO or AM1/COSMO is
the best pKa prediction method, otherwise PM3/SMD or AM1/SMD should be used.
Thus, fast and relatively accurate pKa prediction for 100-1000s of drug-like amines is
feasible with the current setup and relatively modest computational resources.
Introduction
One of the central practical challenges to be met when performing calculations on many
organic molecules in aqueous solution is selecting the correct protonation state at a given
pH. There are several empirical pKa predictors such as ACD pKa DB (ACDLabs, Toronto,
Canada), ChemAxon (ChemAxon, Budapest, Hungary), and Epik (Schro¨dinger, New York,
USA) that rely on large databases of experimental pKa values that are adjusted using empir-
ical substituent-specific rules. As with any empirical approach the accuracy of these methods
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correlate with the similarity of the target molecule to molecules in the database. For ex-
ample, Settimo et al. 1 have recently shown that the empirical methods can fail for some
amines, which represent a large fraction of drugs currently on the market or in development.
This problem could make these methods di cult to apply to computational exploration of
chemical space2–4 where molecules with completely novel chemical substructures are likely
to be encountered.
One possible solution to this problem is electronic structure (QM)-based pKa prediction
methods (see Ho 5 for a review) which in principle requires no empirical input. In prac-
tice, when applied to larger molecules6–8, some degree of empiricism is usually introduced
to increase the accuracy of the predictions but these parameters tend to be much more
transferable because of the underlying QM-model. However, these QM-based methods are
computationally quite demanding and cannot be routinely applied to the very large sets of
molecules typically encountered in high throughput screening.
Semiempirical QM methods such as PM69 and DFTB310 are orders of magnitude faster
than QM methods but retain a flexible and, in principle, more transferable QM description
of the molecules. One of us recently co-authored a proof-of-concept study11 demonstrating
that semiemprical QM methods can be used together with isodesmic reactions to predict pKa
values of small model systems with accuracies similar to QM methods for many functional
groups. However, amines proved the most di cult due to the diverse chemical environment
of the ionizable nitrogen atoms. We hypothesized that the solution to this problem is a
more diverse set of reference molecules and in this study we demonstrate the validity of this
hypothesis for a set of 53 amine groups in 48 drug-like compounds. In addition we test more
semiempirical methods than in the previous study.
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Computational Methodology
The pKa values are computed by
pKa = pK
ref
a +
 G 
RT ln(10)
(1)
where  G  denotes the change in standard free energy for the isodesmic reaction
BH+ + Bref *) B + BrefH
+ (2)
where the standard free energy of molecule X is computed as the sum of the semiempirical
heat of formation, or the electronic energy in case of DFTB3, and the solvation free energy
G (X) =  H f (X) + G
 
solv(X) (3)
All energy terms are computed using solution phase geometries unless noted otherwise.
 H f (X) is computed using either PM6-DH+
12, PM613, PM714, PM315, AM116, or DFTB310
(where the electronic energy is used instead of the heat of formation), while  G solv(X) is
computed using either the SMD17 or COSMO18 solvation method. The SMD calculations are
performed with the GAMESS program19, the latter using the semiempirical PCM interface
developed by Steinmann et al. 20 and the DFTB/PCM interface developed by Nishimoto 21
and using version 3ob-3-1 of the 3OB parameter set10,22–24, while the COSMO calculations
are performed using MOPAC2016. A maximum of 200 optimization cycles are used for so-
lution phase optimizations and a gradient convergence criterion (OPTTOL) of 5⇥ 10 4 au
and delocalized internal coordinates25 are used for GAMESS-based optimization.
This study considers 53 amine groups in 48 drug-like molecules with experimentally mea-
sured amine pKa values taken from Table 3 of the study by Eckert and Klamt 6 . Some of
the smaller molecules in that table, such as 2-methylbenzylamine, were removed since they
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would di↵er very little from the corresponding reference molecules. The reference molecules
are chosen to match the chemical environment of the nitrogen within a two-bond radius
as much as practically possible and including the ring-size if the nitrogen is situated in a
ring. For example, the tertiary amine group in thenyldiamine (Figure 1) has two methyl
groups and a longer aliphatic chain so the reference molecule is dimethylethylamine, rather
than triethylamine used in our previous study. This choice is motivated by our previous
observation11 that, for example, the predicted value of dimethylamine has a relatively large
error when computed using a diethylamine reference. Similarly, the reference compound for
the aromatic nitrogen group in thenyldiamine is 2-aminopyridine, rather than pyridine, to
reflect the fact that the nitrogen is bonded to an aromatic carbon which is bonded to another
aromatic carbon and another nitrogen. In a few cases somewhat larger reference compounds
are chosen if they reflect common structural motifs such as the guanine group in acyclovir or
the  OOC-CH(R)-NH+3 zwitterionic motif in phenylalanine and tryptophan. This approach
resulted in 26 di↵erent reference molecules (Table S1) that reflect typical functional groups
found in drug-like molecules. Most of the reference pKa values are computed using the ACE
JChem pKa predictor26 while the rest are experimental values. The only molecule where it
proved di cult to apply this general approach to identifying a suitable reference molecule is
the imine nitrogen in clozapine (Figure 1) where the nitrogen is bonded to a phenyl group
on one side an a tertiary sp2 carbon that in turn is hydrogen bonded to a nitrogen and a
phenyl group. The reference compound that would result from applying the rules outlined
above (N-phenylbenzamidine, Figure 1) was considered ”too specific” for clozapine. Instead
we searched the already chosen set of 26 reference molecules the molecule with the largest
sub-structure match, which turn out to N-phenylethanimidamide, that was originally chosen
as a reference for phenacaine.
Many of the molecules contain more than one ionizable group. Only the pKa values
of the amine indicated in Eckert and Klamt’s Table 3 are computed and the protonation
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states are prepared according to standard pKa values. For example, for phenylalanine the
carboxyl group is deprotonated because the ”standard” pKa values of a carboxyl group (e.g.
in acetic acid) is lower than the standard pKa values of a primary amine (e.g. ethylamine).
Notice that the cyanoguanidine group in cimetidine has a pKa value of about 027,28 and is
therefore deprotonated when the imidazole group titrates. Eckert and Klamt characterised
the histamine pKa value of 9.7 as an amidine pKa and the thenyldiamine pKa as a pyridine
pKa. This is corrected to a primary amine29 and tertiary amine, respectively. For thenyl-
diamine pKa values of 3.7 and 8.9 have been measured potentiometrically30 and cannot be
assigned to a particular nitrogen experimentally. But based on standard pKa values it it is
likely that the higher pKa value corresponds to the amino group. For example, the ACE
JChem pKa predictor predicts values of 5.6 and 8.8 for the pyridine and amine groups, re-
spectively. This hypothesis is further corroborated by the fact that introducing an additional
N atom to the pyridine ring in neohetramine (Figure 1) only significantly a↵ects the lower
pKa value30. The experimental pKa values of morphine and niacin are changed to 8.231
and 4.232, respectively, while the remaining experimental pKa values are taken from Eckert
and Klamt 6 . When several tautomers are possible all are considered. The protonation and
tautomer states considered can be found in supplementary materials. RDKit33 is used to
generate 20 starting geometries for each protonation state and the lowest free energy struc-
ture for each protonation state is used for the pKa calculations.
The Epik34,35 calculations where performed with version 2016-4 of the Epik program
using coordinates generated from SMILES strings using LigPrep version 2016-4. Default
settings were applied except that the initial ionization state was not changed. Solvent was
selected as water and the pH range as 7.0 ± 2.0. The ChemAxon calculations are performed
using the command line tool cxcalc version 15.12.14.0. The ACD predictions are taken from
the ChEMBL20 database with except the pKa value of nikethamide, which is taken from
ChEMBL19. Versions 20-22 lists a pKa value of 10.1 for nikethamide, which is considerably
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higher than the experimental value of 3.5. Version 19 lists a pKa value of 4.01, which is
in better agreement with experiment so this value was used. The ChEMBL pKa data is
computed using ACDlabs software v12.01
Results and Discussion
PM3- and AM1-based methods
Table 1 lists the predicted pKa values, Figure 2 shows a plot of the errors, and Table 2 lists
the root-mean-square-error (RMSE) and maximum absolute error for each method. The
AM1- and PM3-based methods perform best with RMSE values of 1.4 - 1.6 pH units that
have uncertainties in the 0.2-0.3 pH unit range, which make them statistically equivalent36–38
(see SI for more information). The null model pKa ⇡ pKrefa has an RMSE of 1.8 ± 0.3/0.4.
However, because of the high correlation between the null model and the PM3 and AM1
methods (e.g. r = 0.78 vs PM3/COSMO) the composite errors are relatively small (e.g. 0.2
pH units vs PM3/COSMO) making the lower RMSE observed for AM1 and PM3 statisti-
cally significant. The rest of the methods (PM6-DH+, PM6, PM7, and DFTB3) perform
worse than AM1 and PM3 and are discussed further below.
The negative outlier seen for the COSMO-based methods (Figure 2) is cefadoxil (Figure
1) and is due to proton transfer in the zwitterionic protonation state. For the three other
zwitterions among the molecules, niacin, phenylalanine, and tryptophan, no proton transfer
is observed and the error in the predicted pKa values are relatively small. Proton transfer
in zwitterions is also a common problem for DFT/continuum calculations, for example for
glycine39–41, and is due to deficiencies in the continuum solvent method, not the electronic
structure method. The good performance observed for PM3/SMD is thus due to fortuitous
cancellation of error. Cefadroxil is also the negative outlier for DFTB3/SMD although the
proton does not transfer.
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Table 1: Experimental, reference (cf. Eq 1), and predicted pKa values. ”COS”
stands for COSMO. ”+” and ”-” refers to the charge of the conjugate base.
Molecule Exp Ref PM6-DH+ PM6 PM7 PM3 AM1 PM3 AM1 DFTB3
pKa COS COS COS COS COS SMD SMD SMD
Acebutolol 9.5 10.6 8.2 6.8 10.4 9.4 9.2 6.8 8.8 10.5
Acyclovir 2.2 2.6 0.1 0.3 0.3 1.5 1.0 0.9 1.2 0.9
Alphaprodine 8.7 10.1 6.5 6.5 9.0 8.5 8.6 7.9 8.0 6.2
Alprenolol 9.6 10.6 6.8 6.8 9.1 8.1 8.8 7.4 7.9 8.6
Atenolol 9.6 10.6 8.4 7.2 9.9 9.0 9.4 7.8 8.2 8.1
Benzocaine 2.5 4.6 0.2 0.3 1.3 2.6 1.8 2.6 1.8 0.8
Betahistine 10.0 10.5 9.3 8.7 10.2 8.6 9.5 8.6 8.9 10.6
Betahistine+ 3.9 5.8 2.9 3.8 3.1 4.9 3.3 4.5 2.8 -0.2
Cefadroxil- 7.0 9.5 -2.8 1.2 1.0 0.1 1.6 7.6 4.6 -3.0
Chloroquine 10.6 10.2 9.6 9.1 11.4 9.9 9.9 8.6 9.2 8.3
Cimetidine0 6.8 6.8 6.1 6.1 4.1 5.1 5.5 4.2 5.2 5.3
Clomipramine 9.4 10.2 11.2 10.0 13.6 9.7 9.2 9.4 8.5 8.4
Clotrimazole 5.8 6.6 5.1 5.0 7.3 4.7 5.2 4.0 4.0 4.3
Clozapine 7.5 10.0 5.9 5.7 7.2 8.2 7.8 7.1 7.1 6.2
Clozapine+ 3.9 10.3 5.4 5.6 6.8 2.7 2.5 1.4 1.2 6.6
Codeine 8.1 10.1 6.0 5.7 8.0 7.6 6.2 6.1 4.7 5.4
Desipramine 10.3 10.5 10.8 10.9 11.9 9.9 9.5 9.8 8.9 9.4
Guanethidine 11.4 12.8 14.3 12.4 13.2 13.2 14.0 12.3 12.9 16.2
Histamine 9.7 10.6 9.5 9.5 9.7 8.9 9.9 9.0 9.4 12.9
Hydroquinine 9.1 10.5 7.0 6.4 10.0 8.9 8.9 6.9 8.4 9.7
Hydroquinine+ 4.1 4.5 2.7 2.1 3.8 1.8 2.2 3.1 1.7 3.1
Imipramine 9.6 10.2 9.9 8.9 12.0 9.6 9.3 9.3 8.4 8.6
Labetalol 7.3 10.6 7.0 6.4 9.4 7.5 9.9 7.2 8.4 8.0
Lidocaine 7.9 10.2 3.7 4.2 5.7 5.4 5.7 5.3 5.3 5.9
Maprotiline 10.3 10.5 10.2 10.4 11.7 10.9 10.2 10.5 9.6 10.4
Mechlorethamine 6.4 10.0 4.5 4.2 4.4 5.4 5.8 5.4 6.5 1.3
Metaproterenol 9.9 10.6 9.1 7.6 8.9 8.7 9.7 7.9 8.3 9.2
Metoprolol 9.6 10.6 6.8 6.7 9.8 8.7 9.4 7.3 8.6 9.4
Miconazole 6.4 6.6 5.5 6.0 5.0 5.2 5.4 4.6 5.2 5.1
Morphine 8.2 10.1 5.7 5.5 7.5 7.6 5.6 6.0 4.3 4.9
Nafronyl 9.1 10.2 8.8 6.6 13.3 7.3 7.7 6.9 7.7 8.1
Nefopam 8.5 10.0 6.8 6.8 8.8 7.4 7.8 6.6 7.0 7.9
Niacine- 4.8 5.2 3.9 3.9 6.1 5.4 5.3 4.8 4.1 5.1
Nicotine 8.1 10.3 7.2 7.3 8.1 8.4 8.5 8.3 8.0 7.3
Nicotine+ 3.2 5.2 1.7 1.8 2.4 1.6 1.7 1.4 1.3 -0.7
Nikethamide 3.5 5.2 2.0 2.4 3.6 2.5 2.6 2.0 1.8 2.1
Papaverine 6.4 6.0 3.9 4.4 4.7 4.9 5.0 3.5 4.0 7.3
p-Cl-amphetamine 9.9 10.4 9.0 9.0 10.0 9.2 8.7 8.8 8.2 8.9
Phenacaine 9.3 10.3 10.3 10.1 10.8 8.6 7.7 8.1 6.9 12.2
Phenylalanine- 8.9 9.5 9.7 9.3 10.1 9.4 9.2 8.4 8.1 9.3
Piroxicam 5.3 6.5 5.7 0.5 7.1 6.3 7.7 4.9 6.2 2.3
Prazosin 7.0 7.0 4.6 4.9 6.1 5.0 5.7 4.8 3.6 7.7
Procaine 9.1 10.2 8.6 6.7 10.9 8.6 8.3 8.5 9.1 9.2
Procaine+ 2.0 4.6 -1.0 -0.7 -0.2 2.0 1.4 1.3 0.2 -1.9
Propanolol 9.6 10.6 5.2 6.8 8.8 8.3 8.4 7.5 7.7 8.5
Quinine 8.5 10.5 6.9 6.5 9.6 8.4 8.5 6.5 8.0 8.2
Sotalol 9.3 10.6 7.4 8.1 8.3 9.3 8.0 7.9 7.5 9.1
Sparteine 12.0 10.3 14.4 13.5 15.9 11.7 12.3 10.8 12.1 9.5
Tetracaine 8.5 10.2 9.3 7.8 10.7 9.6 9.0 9.1 9.3 8.7
Thenyldiamine 8.9 10.2 11.5 9.3 13.1 9.4 8.7 9.1 8.5 8.6
Trazodone 6.8 10.2 4.7 3.7 8.1 6.4 6.7 6.2 4.9 6.4
Trimipramine 9.4 10.2 11.9 10.2 13.7 10.2 10.2 9.4 10.1 8.1
Tryptophan- 9.1 9.5 9.6 9.2 11.3 9.5 9.8 8.9 8.4 10.6
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Table 2: Root-mean-square-error (RMSE), statistical uncertainty (95% confi-
dence limits in the RMSE, see SI for more information), and the maximum
absolute error (Max AE) of the pKa (a) the pKa values in Table 1, (b) with
cefradoxil removed, (c) with an empirical o↵set, and (d) using geometries opti-
mized in the gas phase and zwittterions removed (Table S2). ”COS” stands for
COSMO.
Ref PM6-DH+ PM6 PM7 PM3 AM1 PM3 AM1 DFTB3
pKa COS COS COS COS COS SMD SMD SMD
RMSEa 1.8 2.3 2.1 2.0 1.4 1.3 1.5 1.6 2.4
95% conf 1.4-2.1 1.8-2.7 1.6-2.4 1.6-2.4 1.1-1.6 1.1-1.6 1.2-1.8 1.3-1.9 1.9-2.8
Max AE 6.5 9.8 5.8 5.9 6.9 5.4 2.9 3.9 9.9
RMSEb 1.8 1.8 1.9 1.8 1.0 1.1 1.5 1.6 2.0
95% conf 1.4-2.1 1.4-2.2 1.5-2.3 1.4-2.2 0.8-1.2 0.9-1.3 1.2-1.8 1.2-1.9 1.6-2.3
Max AE 6.5 4.4 4.8 4.3 2.5 2.6 2.9 3.9 5.1
RMSEc 1.8 1.6 1.4 1.8 0.9 1.1 1.0 1.1 1.9
95% conf 1.4-2.1 1.3-1.9 1.1-1.7 1.4-2.1 0.7-1.1 0.8-1.2 0.8-1.2 0.9-1.3 1.5-2.2
Max AE 6.5 3.8 3.4 3.7 2.3 3.0 2.1 2.8 5.6
RMSEd 1.8 2.6 2.4 2.1 1.4 1.3 1.9 1.9 3.0
95% conf 1.4-2.1 2.0-3.0 1.8-2.8 1.6-2.5 1.1-1.7 1.0-1.5 1.5-2.2 1.5-2.2 2.4-3.6
Max AE 6.5 7.8 4.6 5.2 3.5 2.5 4.3 3.8 11.1
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If the cefadroxil outlier is removed, the RMSE values for PM3/COSMO and AM1/COSMO
drop to 1.0 ± 0.2 and 1.1 ± 0.2, while PM3/SMD and AM1/SMD remain at 1.5 ± 0.3 and
1.6 ± 0.3/0.4 pH units. Thus, without this outlier the COSMO-based predictions outperform
the SMD-based predictions, as well as the null model. For pKa calculations where a zwit-
terionic state is not involved or proton transfer in a zwitterionic state is not observed then
PM3/COSMO or AM1/COSMO is the best pKa prediction method, otherwise PM3/SMD
or AM1/SMD should be used. The main reason for performing solution-phase geometry op-
timisations was the possible presence of zwitterions, so if a zwitterionic state is not involved
then the geometry optimisations could potentially be done in the gas phase. Table 2 shows
that PM3/COSMO and AM1/COSMO continue to perform best with RMSEs of 1.4 ± 0.3
and 1.3 ± 0.2/0.3 pH units, respectively (the pKa values can be found in Table S2). The
largest di↵erence in RMSEs is observed for PM3/COSMO(soln) and PM3/COSMO(gas)
(0.4 pH units) and is larger than the composite error of 0.1 pH units for these two error. So
using gas phase geometries for non-zwitterionic molecules leads to a statistically significant
decrease in the accuracy of the pKa predictions.
Figure 2 shows that all semiempirical methods except PM7 tend to underestimate the
pKa values. The mean signed errors for PM3/COSMO and AM1/COSMO are -0.4 and
-0.5 pH units while they are -1.1 for both PM3/SMD and AM1/SMD (computed without
cefadoxil). If these mean errors are included as an empirical correction to the pKa values
then the accuracy of the COSMO- and SMD-based methods become statistically identical
with RMSE values of between 0.9 and 1.1 pH units (Table 2). However, it remains to be
seen whether these corrections are transferable to other sets of amines.
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PM6-DH+-, PM6- and PM7-based methods
In addition to their chemical importance pKa values are also useful benchmarking tools that
can help in identifying problems with theoretical methods. Here we compare the results for
PM6-DH+/COSMO, PM6/COSMO- and PM7/COSMO-based methods to PM3/COSMO
to gain some insight in to why these methods lead to less accurate pKa predictions with
RMSE values of 1.9 compared to 1.0 (ignoring cefadroxil).
Compared to PM3, PM6-DH+ has two outliers: propranolol and lidocaine (Figure 2). For
propanolol PM6-DH+ predicts a pKa value of 5.2, which is significantly lower than the exper-
imental value of 9.6 and that predicted by PM3 (8.3). Comparison of the lowest free energy
structures for the protonated state shown in Figure 3a-b shows that the PM6-DH+ struc-
ture is significantly more compact than the PM3 structure with the isopropylaminoethanol
chain stacked on the face with the naphthalene group. This will lead to desolvation of the
amine group and will lower the predicted pKa. This structure is also the lowest free energy
structure for PM6 where the predicted pKa value is 6.8. So the compactness is not solely due
to the dispersion interactions included in PM6-DH+, as one might expect, but these forces
do contribute to the very low pKa value. It is important to emphasize that this does not
necessarily imply that the dispersion interactions are overestimated by the DH+ corrected,
but rather that they possibly are too large compared to the solute/solvent interactions in
the COSMO solvation model when using PM6-DH+ to describe the solute. This general
point also applies to the rest of the analyses presented below.
For lidocaine PM6-DH+ predicts a pKa value of 3.7 pH units, which is significantly
lower than the experimental value of 7.9 and that predicted by PM3 (5.4). Comparison
of the lowest free energy structures for the protonated state shown in Figure 3c-d shows
that the NH-O hydrogen bond-like interaction observed in the PM3 structure is absent in
the PM6-DH+ structure, which is consistent with a lower pKa value. The hydrogen bond,
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which is also present in the lowest free energy PM6 structure, is replaced by non-polar in-
teractions between methyl groups which presumably are stronger in PM6-DH+ due to the
dispersion forces.
Compared to PM3, PM6 has one outliers (Figure 2), piroxicam, where PM6 predicts a
pKa value of 0.5, which is significantly lower than the experimental value of 5.3 and that
predicted by PM3 (6.3). Comparison of the lowest free energy structures for the protonated
state shown in Figure 4 shows that the pyridine NH hydrogen bond to the amide O observed
in the PM3 structure is replaced by a presumably unfavorable NH-HN interaction with the
amide group, which indeed should lower the pKa considerably. Both PM3 and PM6 geom-
etry optimisations are performed with exactly the same set of starting structures and it is
not immediately clear why this arrangement leads to lowest free energy, but it is presumably
due to an increase in the solvation energy.
Compared to PM3, PM7 has three outliers (Figure 2): spartein, trimipramine, and
thenyldiamine. For propanolol PM7 predicts a pKa value of 15.9, which is significantly
higher than the experimental value of 12.0 and that predicted by PM3 (11.7). Comparison
of the lowest free energy structures for the protonated state shown in Figure 5a-b shows
virtually no di↵erence in structure. The same is found for the low free energy structures of
the conjugate base and both protonation states of the reference molecule. The most likely
explanation for the overestimation is therefore that the NH-N hydrogen bond strength is
overestimated compared to PM3. This theory is further corroborated for trimiparine where
PM7 predicts a pKa value of 13.7 pH units, which is significantly higher than the experi-
mental value of 9.4 and that predicted by PM3 (10.2). Comparison of the lowest free energy
structures for the protonated state shown in Figure 5c-d shows a NH-N hydrogen bond for
the PM7 structure, which is absent in the PM3 structure. This structural di↵erence is con-
sistent with both the higher pKa and an overestimation of NH-N hydrogen bond strength by
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PM7. Finally, for thenyldiamine PM7 predicts a pKa value of 13.1 pH units, which again is
significantly higher than the experimental value of 8.9 and that predicted by PM3 (9.4). The
main di↵erence in structure between the free energy minima (Figure 5e-f) is an apparently
stronger interaction between the thiophene ring and the amine in the PM7 structure, which,
if anything, should desolvate the amine group and lower the pKa value. The most likely
explanation for the overestimation is thus an overestimation of the NH-N hydrogen bond as
in the the other two cases.
DFTB3/SMD
Compared to PM3/COSMO, DFTB3/SMD has five outliers (Figure 2) and here we focus
on the two with the largest errors: guanethidine and mechlorethamine. For guanethidine
DFTB3 predicts a pKa value of 16.2 pH units, which is significantly higher than the experi-
mental value of 11.4 and that predicted by PM3 (13.2). Comparison of the lowest free energy
structures for the protonated state shown in Figure 6a-b shows that they are quite similar
with a NH-N hydrogen bond, but with the 7-membered ring in a slightly di↵erent confor-
mation. The hydrogen bond length in the DFTB3 structure is 2.33 A˚, which is significantly
shorter than the 2.56 A˚in the PM3 structure. A stronger hydrogen bond is consistent with
a higher pKa, but the errors for DFTB3 are not unusually larger for, for example, sparteine,
trimipramine, and thenyldiamine. One possibility is that it is only guanine NH hydrogen
bond strengths that are overestimated but this can not be verified with the current set of
molecules.
For mechlorethamine DFTB3 predicts a pKa value of 1.3 pH units, which is significantly
lower than the experimental value of 6.4 and that predicted by PM3 (5.4). Comparison of
the lowest free energy structures for the protonated state shown in Figure 6c-d shows over-
all similar structures. In both cases the amine hydrogen is surrounded by the two chlorine
atoms, which lowers the pKa value due to desolvation. However, closer inspection of the
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structures reveal that for the DFTB3 structure the chlorine atoms are significantly closer
together and one of the chlorine atoms is significantly closer to the amine hydrogen. These
structural di↵erences are consistent with greater desolvation in the DFTB3 structure and,
hence, a lower pKa value.
With regard to DFTB3 it is also noteworthy that two molecules fragment in the DFTB3
gas phase geometry optimisations: in the case of the niacin zwitterion CO2 is eliminated
while for the protonated form of sotalol CH3SO2 is eliminated. Barrier-less CO2 has been
previously observed for DFTB3 for model systems of L-aspartate ↵-decarboxylase42 and is
presumably due to the 16.8 kcal/mol error in the atomisation energy of CO2 for DFTB310.
Prediction of dominant protonation state
One of the main uses of pKa values is the prediction of the correct protonation state at
physiological pH (7.4), i.e. determining whether the predicted pKa value is above or below
7.4. Here (ignoring cefadroxil) PM3/COSMO performs best by getting it right 94% of the
time, compared to 90%, 79%, and 92% for AM1/COSMO, PM3/SMD, and the null model.
Thus, only PM3/COSMO outperforms the null model. PM3/COSMO fails in three cases,
labetalol, lidocaine, and nafronyl, where PM3/COSMO predicts pKa values of 7.5, 5.4, and
7.3, respectively and the corresponding experimental values are 7.3, 7.9, and 9.1 pH units.
The null model fails in four cases, clozapine (amide nitrogen), labetalol, mechlorethamine,
and trazodone, where the null model predicts pKa values of 10.3, 10.6, 10.0, and 10.2 and
the corresponding experimental values are 3.9, 7.3, 6.4, and 6.8 pH units, respectively. Thus,
both methods fail for only one ionizable site where the experimentally measured pKa value
is significantly di↵erent from physiological pH.
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Table 3: Root-mean-square-error (RMSE), statistical uncertainty (95% confi-
dence limits) in the RMSE, and the maximum absolute error (Max AE) of the
pKa for the pKa values listed in Table S3
PM3 PM3 DFT Chem Epik ACD
COS COS* Axon
RMSE 1.0 0.9 0.7 0.7 0.7 0.6
95% conf 0.8-1.2 0.7-1.1 0.5-0.8 0.6-0.9 0.6-0.8 0.5-0.7
Max AE 2.5 2.3 1.9 2.8 3.6 2.0
Comparison to other pKa prediction methods
Figure 7 and Table 3 compares the two best semiempirical methods PM3/COSMO and
PM3/COSMO*, where the pKa values are shifted to make the average error zero, to the
DFT results of Eckert and Klamt 6 and three popular empirical pKa prediction methods. In
all cases cefadroxil has been removed. The RMSE values of the DFT and empirical meth-
ods are 0.6-0.7, 0.2-0.3 pH units lower than the best semiempirical method PM3/COSMO*.
Thus, the accuracy of DFT results are statistically equivalent to the empirical methods,
while the semiempirical methods are statistically worse. The good performance of the em-
pirical methods for this set of molecules is not surprising. The set represents well known
and prototypical drug molecules whose pKa values have been known for a long time and
many of the molecules are likely included in the parameterization of the empirical methods.
For example, many of the molecules are taken from the set collected by Klici et al. 7 , which
is also included in the training set used to develop Epik.34 It is therefore gratifying to see
that the DFT results by Eckert and Klamt 6 , which only contains two adjustable parameters
determined using the di↵erent set of data, are just as accurate albeit at a much higher com-
putational cost. The computational cost of the DFT method is ca 1000 times larger than
that of the semiempirical methods, while the computational cost of the empirical methods
is essentially zero compared to the semiempirical methods.
As mentioned in the introduction, one potential use of the QM-based pKa prediction
methods is for cases where the empirical methods fail. Figure 7 shows that, for example,
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ChemAxon has two outliers while Epik has one outlier where the error is larger than for
the QM-based predictions. The Epik outlier is observed for sparteine, which is also the
one of the outliers observed for ChemAxon, as well as one of the largest errors observed
for ACD. The absolute errors for these methods range from 1.9 to 3.6, while the errors
for PM3/COSMO(*) and DFT are between 0.2 and 0.4 pKa units. Similarly, the other
ChemAxon outlier is observed for labetalol, which is also gives rise to the second and third
largest error for Epik and ACD, respectively. The absolute errors for these methods range
from 1.6 to 2.5, while the errors for PM3/COSMO(*) and DFT are between 0.0 and 0.7 pKa
units. These cases suggest that QM-based pKa prediction methods can be of practical use
despite their comparatively high computational cost.
Timings
A MOPAC-based geometry optimization requires no more than about 10-20 CPU seconds
on a single core CPU even for the largest molecules considered here (e.g. clozapine), whereas
corresponding GAMESS optimizations take about 60-90 seconds. Thus, using 20 di↵erent
starting geometries for each protonation state a pKa value can be predicted in a few CPU
minutes using a single 12-CPU node. In practice the wall-clock time is longer due to the
overhead involved in having all cores write output files to disk simultaneously. Similarly,
most queuing software has an some computational overhead which becomes noticeable when
a large number of sub-minute jobs are submitted simultaneously. These general problems
need to be addressed if semiempirical methods are to be used e ciently in very large-scale
high throughput studies. Nevertheless, fast pKa predictions for 100-1000s of molecules is
feasible with the current setup and relatively modest computational resources.
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Summary and Outlook
This study uses PM6-DH+/COSMO, PM6/COSMO, PM7/COSMO, PM3/COSMO, AM1/COSMO,
PM3/SMD, AM1/SMD, and DFTB3/SMD to predict the pKa values of 53 amine groups
in 48 drug-like compounds. The approach uses isodesmic reactions where the pKa values
is computed relative to a chemically related reference compound for which the pKa value
has been measured experimentally or estimated using an standard empirical approach. Both
gas phase and solution phase geometry optimisations are tested. The AM1- and PM3-based
methods using solution phase geometries perform best with RMSE values of 1.4 - 1.6 pH
units that have uncertainties of 0.2-0.3 pH units, which make them statistically equivalent.
However, for all but PM3/SMD and AM1/SMD the RMSEs is dominated by a single outlier,
cefadoxil, caused by proton transfer in the zwitterionic protonation state. If this outlier is
removed, the RMSE values for PM3/COSMO and AM1/COSMO drop to 1.0 ± 0.2 and 1.1
± 0.3, while PM3/SMD and AM1/SMD remain at 1.5 ± 0.3 and 1.6 ± 0.3/0.4 pH units.
Thus, without this outlier the COSMO-based predictions outperform the SMD-based pre-
dictions, so for pKa calculations where a zwitterionic state is not involved or proton transfer
in a zwitterionic state is not observed then PM3/COSMO or AM1/COSMO is the best pKa
prediction method, otherwise PM3/SMD or AM1/SMD should be used. Thus, fast and rel-
atively accurate pKa predictions for 100-1000s of molecules is feasible with the current setup
and relatively modest computational resources.
For the current study the reference molecules were selected by hand to match the local
structure around the ionizable as much as possible for most molecules to maximize the can-
cellation of error and improve accuracy as much as possible. This approach will work well
when the pKa of a small number of molecules is needed or if the e↵ect of substituents on
the pKa of an ionizable group in a target molecule is to be investigated. However, for high
throughput pKa prediction for a very large and diverse set of molecules it will not always
be practically possible to identify closely related reference molecules and for such a case the
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overall accuracy is likely to be worse than reported here. How much worse remains to be
seen but recalculating the PM3/COSMO pKa values (without cefadroxil) using only nine
reference compounds (Table S4) results in an RMSE value of 1.2, i.e. only 0.2 pH units
higher than that computed using 26 reference values - an encouraging result. After this
paper was submitted, Bochevarov et al. 8 published a paper on DFT-based pKa prediction
where they defined linear regression parameters for roughly 100 di↵erent ionizable functional
groups and outlined a hierarchical model for choosing the most appropriate parameter set.
This interesting approach could serve as a basis for a defining a more generally applicable
set of reference molecules in future work. The current implementation also relies on manual
selection of the protonation state of other ionizable groups, which in cases like cimetidine
requires expert knowledge. In the general case this step needs to be automated by generating
all possible protonation isomers for a given protonation state and selecting the one with the
lowest free energy. Work on full automation of the process is ongoing.
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Figure 1: Some of the molecules referred to in the text
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Figure 2: Plot of the errors of the predicted pKa values (pKa   pKExpa ). ”C” and ”S” stand
for COSMO and SMD, respectively.
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Figure 3: Lowest free energy conformations of (a-b) propanolol and (c-d) lidocaine at the
PM3/COSMO (a and c) and PM6-DH+/COSMO (b and d) level of theory. Hydrogen bonds
are indicated with dashed lines.
27
Figure 4: Lowest free energy conformations of piroxicam at the (a) PM3/COSMO and (b)
PM6/COSMO level of theory. Hydrogen bonds are indicated with dashed lines.
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Figure 5: Lowest free energy conformations of (a-b) sparteine, (c-d) trimipramine, and (e-f)
thenyldiamine at the PM3/COSMO (a, c, and e) and PM7/COSMO (b, d, and f) level of
theory. Hydrogen bonds are indicated with dashed lines.
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Figure 6: Lowest free energy conformations of (a-b) guanethidine and (c-d) mechlorethamine
at the PM3/COSMO (a and c) and DFTB3/SMD (b and d) level of theory. Distances are
given in A˚.
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Figure 7: Plot of the errors of the predicted pKa values (pKa   pKExpa ). ”C” stands for
COSMO and ”*” indicates that the pKa values have been shifted to make the average error
zero
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